SOMERSET, N.J., Jan. 6, 2015 – The number of nations that logged onto the Post-Finasteride Syndrome Foundation website jumped 22 percent in 2014, according to Google Analytics.
In all, users in 157 countries—or 81 percent of the world (as defined by the 195 nations recognized by the U.S. Department of State)—accessed information on the condition via PFSFoundation.org, versus 129 countries during the period from the website’s launch in August 2012 through 2013.
Visits from outside the U.S. comprised 54 percent of the site’s total annual traffic in 2014.
Additionally, the total number of unique visitors to the site rose 64 percent in 2014 compared to 2013.
Separately, between June 2009 and June 2014, via its MedWatch program, the U.S. Food and Drug Administration received reports of adverse finasteride events from patients and health care professionals in 33 nations outside the U.S., including the U.K., Japan, France, Germany, Canada, Denmark, China, Italy, Spain and Israel.
PFS has been reported to occur in men who have taken the prescription drug finasteride to treat hair loss (under the brand name Propecia and generics), or enlarged prostates (Proscar and generics).
Reported symptoms include loss of libido, erectile dysfunction, depression, suicidal ideation, anxiety, panic attacks, Peyronie’s disease, penile shrinkage, gynecomastia, muscle atrophy, cognitive impairment, insomnia, severely dry skin, and tinnitus. The condition often has a life-altering impact on victims and their families, such as job loss and the breakup of marriages and romantic relationships, while also being linked to suicides.
“At this current rate of expanding awareness, we’re likely to see users from most every nation on earth educating themselves on PFS before the decade is out,” said PFS Foundation CEO Dr. John Santmann.
Following are analytics surrounding PFSFoundation.org use during 2014:
Site popularity by nation (top 50 of 157)
1: USA
2: United Kingdom
3: Germany
4: Canada
5: Japan
6: Brazil
7: Italy
8: Australia
9: Turkey
10: India
11: Spain
12: Ireland
13: Netherlands
14: Sweden
15: Switzerland
16: South Korea
17: Poland
18: France
19: Norway
20: Argentina
21: Finland
22: Israel
23: Belgium
24: Austria
25: Greece
26: Croatia
27: Singapore
28: Portugal
29: Denmark
30: Mexico
31: New Zealand
32: Iran
33: Thailand
34: South Africa
35: Hong Kong
36: Russia
37: Indonesia
38: Philippines
39: United Arab Emirates
40: Chile
41: Pakistan
42: Slovenia
43: Romania
44: Saudi Arabia
45: China
46: Malaysia
47: Serbia
48: Taiwan
49: Colombia
50: Uruguay
Site popularity by U.S. states (top 25 of all 50 + Washington, DC)
1: California
2: New York
3: Texas
4: Massachusetts
5: Florida
6: Pennsylvania
7: Illinois
8: New Jersey
9: Kentucky
10: Nevada
11: Michigan
12: Georgia
13: Virginia
14: Ohio
15: Washington
16: District of Columbia
17: North Carolina
18: Tennessee
19: Maryland
20: Minnesota
21: Connecticut
22: Colorado
23: Oregon
24: Arizona
25: Indiana
Site popularity by language (top 25 of 116*)
1: English
2: German
3: Portugeuse
4: Japanese
5: Turkish
6: Italian
7: Spanish
8: Dutch
9: Polish
10: French
11: Swedish
12: Korean
13: Norwegian
14: Greek
15: Finish
16: Danish
17: Chinese
18: Hebrew
19: Russian
20: Danish
21: Hungarian
22: Croatian
23: Slovene
24: Arabic
25: Thai
*Includes different national varieties, such as American English, British English and Australian English.
Top 10 most popular landing pages
1: Home page
4: Medical Awareness: Doctors Begin Recruiting PFS Patients for Research Studies
5: Published PFS Clinical Research
6: News release: Clinical Study of Post-Finasteride Syndrome Launched at Brigham and Women’s Hospital
7: News release: Clinical Study of Post-Finasteride Syndrome Launched at Baylor College of Medicine
9: PFS Clinical Research Initiatives
10: Donate
Users by age group
- 25-34: 33.5%
- 18-24: 27.5%
- 35-44: 15.5%
- 45-54: 12.5%
- 55-64: 5.5%
- 65+: 5.5%
Users by gender
- Male: 54.15%
- Female: 45.85%
Following, in order of popularity, are the nations from which patients and health care professionals filed adverse finasteride events to the FDA between June 2009 and June 2014:
All 34 countries
1: USA
2: United Kingdom
3: Japan
4: France
5: Germany
6: Canada
7: Denmark
8: China
9: Italy
10: Spain
11: Israel
12: Korea
13: Sweden
14: Netherlands
15: Australia
16: Switzerland
17: Ireland
18: Poland
19: Saudi Arabia
20: Norway
21: Singapore
22: Taiwan
23: Hong Kong
24: Croatia
25: Turkey
26: Argentina
27: Austria
28: Belgium
29: Bangladesh
30: Brazil
31: Greece
32: Peru
33: Russia
34: Ukraine
About the PFS Foundation
Headquartered in Somerset N.J., the Post-Finasteride Syndrome Foundation was established in July 2012 as a 501(c)(3) organization, with private grants from families in the U.S. and abroad. Tax-deductible financial donations to the nonprofit organization can be made via PFSFoundation.org, which also houses patient-recruitment information on active clinical studies, published research, research goals, and media reports about PFS.
# # #
Contact
Philip Roberts
Post-Finasteride Syndrome Foundation
proberts@pfsfoundation.org
(856)425-6046